John Jumper, Nobel Prize in Chemistry 2024: Official interview

Scientists won the Nobel Prize
12 followers
1 Video View·May 9, 2025
It's easier to learn science than people imagine.
So I guess my childhood, I grew up in Arkansas,
just outside Little Rock.
So I grew up on a farm, not really a working farm,
but you know, horses, dogs, cats, that sort of thing.
And it's about 10, 12 acres.
And really grew up, you know,
my parents were both engineers.
So always kind of very practical,
very oriented in doing this to make something,
to build something.
And I, at some point, and I feel like it was probably
10, 12, somewhere around that age,
kind of started to fall in love really with science
and especially physics.
And I got very, very excited about physics,
would read everything I could.
I was at, you know, just the right age
that you could read everything on the internet.
I was born in 85.
So, you know, by the mid 90s,
the internet was going well, right?
You know, everyone my age remembers the AOL dial-up sounds.
And I really fell in love with physics.
And I remember my parents being a little bit worried
about whether I could really get a job doing science.
And it wasn't such a thing in Arkansas,
but they were very supportive.
And so I loved it.
And I remember just reading this and reading
and really loving also kind of this golden age of physics,
this time in which kind of we discovered quantum mechanics
and special relativity and all these extraordinary things
that we almost had no right to know,
this kind of beautiful facts about the universe.
And so, yeah, I was really, I don't know,
I just somehow loved it.
And I grew up, you know, in a lovely childhood in nature,
doing all these things, loving mathematics.
And it was a great time.
Certainly my father who worked at this company, BEI,
that made really impressive, basically parts for satellites
and other applications, like a part on the Hubble
and being like next to this extraordinarily,
someone who worked on these really, really important things
I think was important.
As I went into college and I was a physics major,
I think really, you know, I was really,
there was a professor, Med Webster,
who taught actually the lab section for modern physics,
one of the first physics classes I took.
And he was just like so kind of precise and insightful.
He would, he knew so much about physics,
but he also, you know, if he asked you a question,
you gave the right answer, but you weren't sure
he would know.
And there was this just really, to me,
like this kind of perfect gentleman physicist
who was really embedded in this,
was really doing these things.
And I fell in love with that.
And that really through college.
And then I think maybe the other
really formative experience actually is like,
I went to graduate school for a PhD originally in physics,
and it didn't quite grab me.
And exactly what I was working on,
and my advisor was a really, you know, good person,
but it just, the research didn't grab me.
And I dropped out of my PhD to go,
do a, to go basically get a job
because it was too late to apply to American grad schools
when I just decided to drop out.
I thought I might go back, maybe do math,
maybe do physics and something else.
And I ended up working at this company,
D.E. Shaw Research and run by David Shaw.
And they were doing biology and biology on computers.
And they were really trying to simulate how proteins move.
And I remember what was absolutely formative
is they were deadly serious.
We're trying to do this really hard computational problem
so we understand proteins,
so we can, you know, contribute to cures for these diseases.
And we are studying this protein
and specifically this change in this protein
because we can connect it out to lung cancer
and everything else.
And it was just kind of this transformative thing
that you can, one thing, you know,
get together in a team and really try and solve
a really hard problem, not just kind of increment it a bit.
And we're doing this because it will mat,
because, you know, it's the difference
whether people go home from the hospital.
And I think just this whole like connection
from what I, you know, loved and I thought I was good at
and like the world of mathematics
and atoms and computation.
And I love these things out to health
and its real impact on society.
And I fell in love with that.
And it was absolutely kind of formative.
And then I went back to grad school
and chemistry almost by accident.
That's another story you should ask me about.
But anyway, and that's, and really was like,
let's use computers to solve biology problems.
This will really matter and people will care.
Twice in my career, I've had complete accidents.
You know, I started with a plan
and the plan was to be a laws of the universe physicist.
And I kind of disabused myself of that.
The timescales were really, really long.
A story I like to tell is a true story
is I wanted to be originally a high energy physicist.
And I did some undergraduate research.
There's some really good high energy groups at Vanderbilt.
I did my undergraduate.
And we got lunch one day and I said,
this experiment we're working on,
when is it gonna turn on?
This was the B-TEB experiment.
And the professor sitting next to me said,
well, you know, I might be retired by then.
It's gonna be a while.
And the professor sitting next to him says,
I'm a bit older.
I might not be around when this turns on.
And I just decided I wanted to do
a little more immediate science than that.
I didn't have quite the patience.
That's important, but I didn't have the patience for that.
And that was kind of the first kind of shift.
And I go to grad school, or my original PhD,
and then I drop out.
And I actually applied for finance jobs,
thinking I was gonna work a year or two.
I was an unemployed physicist.
And I end up instead working in computational biology
and falling in love with it.
But then the kind of third bit of absolute randomness
is that my wife, Carolyn, who's here with me today,
she decided she wanted to go to graduate school
to get a PhD as well in genetics.
And I was gonna do what I had kind of intended
in physics or math, I think more physics.
And so we all applied to grad schools.
And if you and your wife were applying to grad schools,
you need to apply to the same places, right?
Because it's like five, six years,
and I'm not gonna live apart from her for five or six years.
And we applied to all the same places,
except one of the places was UChicago,
but I missed the application deadline.
It closed at five.
I thought it was gonna close at midnight.
And so I missed the deadline to Chicago.
And I said, what's the chance
the one place I wanna go is Chicago?
And so a few months later,
my wife has a great offer from Chicago Genetics.
That's by far her best offer.
I have great offers elsewhere, but nothing in Chicago.
And for like a month,
I try and convince Chicago Physics to let me apply late.
And they quite reasonably said no,
maybe next year, that kind of thing.
And I'm telling the story to a coworker.
And he says something like,
well, do you think you could be a chemist?
I know this professor in UChicago chemistry
that I overlapped with in my postdoc.
And I said, well, and at this point,
I hadn't taken a chemistry class since high school.
I said, sure, I can be a chemist.
You know, how hard can this be, right?
Whatever it takes to get me out of this problem.
And so he must've said a very nice thing to this professor.
And so I talked to this professor
and a week later or something,
they say, we're gonna open the application for you
for one day.
And then they pretty immediately accept me
and I became a chemist.
And so I had to learn general chemistry
one week ahead of the students
for the class that I was TAing.
But yeah, so that's the way I became
a literal card carrying chemist.
And, but apparently I've now won the chemistry Nobel,
maybe for biology, but it still counts.
I think it's really, really important
for scientists to know really well
all the aspects of their work.
I think it's not enough to me to bring together
an interdisciplinary group of people
where you grab a computer scientist
and a biologist and a physicist or something
and put them in a room.
As a person, I think it's really, really important
that you learn these fields,
that you go talk to the people who are really good at it.
I had these kind of formative experiences.
For example, I learned computer science
by going to computer scientist lunches and seminars
and learning what they actually care about
and how they think about it.
And I think it's so much more valuable
or, you know, and then I would go to biologists, to chemists.
I think it's really, really important
as a person to experience and find the experts
in those fields and learn how they think
and then bring it back to your work.
And so we both work in interdisciplinary teams,
but also build interdisciplinary people.
And I remember when we were working on this project,
we would run reading groups, which is quite common.
This is where you would discuss some recent paper.
And we made a pretty intentional decision
that we would do either the reading groups
or about half and half the reading group
on the latest in computer science or machine learning.
Like what were the things people were really thinking about
just from a computer science lens?
Or we would think about, you know,
biology and read recent biology papers.
What do they care about?
How do they think about it?
How do they measure their data?
And actually read less.
We built the interdisciplinary ourselves.
We kind of tried to get the best of those fields.
And I think that's really important.
And we started with a team
that I was the most biological of the team.
And, you know, I went from the worst biologists
in my biophysics lab to the best biologists
at the time the team started.
And Catherine's a better biologist than me.
And she came on later, although as a computer scientist.
But, and you know, a team that was mainly physicists,
computer scientists, et cetera.
And, you know, taught them structural biology.
And I think it's a fun way.
I recommend it.
And it's, I think biology is such a wide subject
that it's easier in some ways to learn biology
than it is to learn, you know, computing or AI,
which have a longer progression to get to the edge.
I came into AI from kind of the other side.
I came from the simulation computing,
like we will write down really proper laws of physics
and then we shall simulate them.
And that's kind of the story we tell.
We will study, we'll write down the laws of the universe
and then we shall play it forward like a clock, right?
Or like some grand machine.
But then when you actually go and do it,
you find people adjusting stuff that doesn't match reality.
Let's change these equations.
Let's make them simpler so we can compute them.
Let's do all these things.
And so like the way that people study nature
isn't as clean as you imagined it coming
as we tell people in school, even in college,
that we, you know, these are the laws
and then we simulate them.
It's really a messy empirical discussion with data.
And when I was at my job at D.E. Shaw,
we had these amazing computers for simulating.
You know, they built custom computers
down to the computer chips themselves.
And a hundred times faster than any supercomputer
in the world, a thousand times faster than most
that this narrow problem of simulating how proteins move.
And then I went to my grad school and I didn't have that.
And I didn't wanna go.
And so I was still interested
in the same scientific questions,
but I didn't have the same computational instrument
as I had before.
And so it became a really active goal.
Can I replace with algorithms, with machine learning?
You know, what I didn't have in hardware,
I was gonna try and build with algorithms and ideas.
And so that's really,
that was my direction of travel into it.
I think a couple pieces of advice I would give.
One is simply that my path
and the path of many other people isn't straight.
People don't end up doing the thing they were trained to do.
We're trained to do the problems
that people knew how to solve in the past, not the new ones.
So I think part of it is not being afraid
to be a little bit myopic,
to really go after the interesting thing tomorrow
to get that new skill.
I think the other piece of advice I would really give
is to meet many communities.
Don't live within this narrow discipline and community.
And I meet a lot of grad students
who only go to their lab meeting
and then they go to the seminar of the department they're in
and they learn a bit, but it's ultimately narrow.
They never go to the department even down the hall
or go and really see the breadth of science
that's being done.
And they miss the opportunity to import ideas
and perspectives from all over.
And people, it's easier to learn science than people imagine.
I think it's like learning a language.
Learning your second language is really hard.
Learning your fifth is not so bad.
As you kind of dive into more disciplines,
you'll find you have this incredible
kind of ability to learn that people don't realize
that they've learned more about how to learn
than they've learned about their subject.
And that makes it much easier to pick up
all these other things if you go after it.
It's worth it.
I think there's a couple perspectives of failure
and we fail on many scales.
I like to say if nine out of 10 of your ideas
as a AI research scientist are failures,
you're the most productive person I know.
It's just incredibly hard.
We have guesses about what to do
and then we learn from trying those guesses.
The important thing about failure is to do it quickly.
Actually, a lot of what I would spend my time doing
with the Alpha Fold team would be talking people
into the smallest version of their idea.
Because then everyone would come and say,
I have a great idea, and they'll describe something
and I'll say, but that would take two months.
It will be two months for you to test that idea.
It's so grand.
What's the two-day version of testing the same idea?
And eventually, often you could come up with,
well, if that works, then we can change this line
from a plus to a minus and then see what happens
or add this term.
And the important thing about failure
is you do it really, really fast.
If you just accept that you're gonna have a 90% failure rate
and you should just accept that in machine learning,
well, then you need to try 10 ideas a month
so you can have one success a month.
So it really is about how fast can you fail.
And I would also say that it's about also,
and I tell this to a lot of young scientists,
it's not about proving your idea could never work.
A lot of people get obsessed at deciding
whether an idea could work or never work.
It doesn't really work that way.
You're just trying to figure out
what you should do tomorrow,
what has got the best chance of succeeding tomorrow.
Often that's what you're doing today, right?
You have the investment.
It's a good idea to try it again,
try a variant of the idea tomorrow,
but really stop focusing so much on being right or wrong
as taking the good shots
that will ultimately lead to success
and being very efficient
with this precious resource we have of our time.
You should always learn from your failures
and you should always learn as much as you can.
And really good scientists that I've seen
and myself on a good day,
learn a lot from the failures and the successes.
They extract information about the problem
and it's not really a failure.
The failure is when you learn nothing about the problem.
And sometimes you do, you take your shot,
it doesn't work and you get on with life.
But that's the important part
that you know more about the problem,
that you've constrained the set of solutions
or non-solutions.
I would say in terms of access,
two things are really important.
One thing that's really important
is just a really clear description of how the thing works.
And to me, that is the heart of the papers,
that there needs to be a description of the thing
that would let someone else build it and reproduce it.
That's the soul of the scientific paper.
It's also, I think, really important
that scientists have access.
And what access really means
and our open release of AlphaFold2 as software
was really important because the community built on it
in all sorts of creative ways.
I like to jokingly refer to it
as off-label uses of AlphaFold, right?
So we had a very clear goal and intention
and problem we were trying to solve, right?
How do we predict the structure of one protein
from the sequence of that protein?
And as soon as it was released,
we saw this explosion of creativity in the field
of people doing really exciting stuff.
Like almost immediately, someone posted on Twitter,
if you take two proteins
and stitch their sequence together with glycine,
which is a standard thing to stick them together,
it will predict how proteins bind to each other,
two different proteins that bind.
Oh, wow.
You know, someone else had another variant of that trick.
And almost immediately, people started to explore
and use their own creativity.
And we see this a lot actually recently
in finding new biology with this.
And like one paper I really love, published in Cell,
they knew that there was some missing protein
in how egg and sperm come together
and make what's called the fertilization complex, right?
How do they recognize each other biochemically?
And they had a list of 2000 proteins
that are on the surface of sperm
known from some other studies.
So they just ran all of those through AlphaFold
to see which ones could AlphaFold stick up
against this fertilization complex.
And they found one clear hit
and actually another group in Sweden also found this hit.
And then this group really tested it experimentally
and showed that was the right protein.
If you take it out, then the egg and sperm won't,
you won't have fertilization events, et cetera, et cetera,
doing the biochemistry of confirming this.
But it's because they did 2000 predictions.
You would never solve 2000 protein structures, right?
It's a year per structure or so.
It's really doing new types of science
because you have access.
Part of what I think is important about open access
is it lets people use it in ways
the creators don't know about, haven't intended.
And it's, you know, there's so much biology, it's a tool.
And, you know, I like to say, you know,
on a really good day,
maybe we're making structural biology
as a whole 5% more efficient.
That's extraordinary, right?
That's really, really exciting.
And of course, some people have
absolutely transformative applications in their area,
but as a whole, it's important to have access to these tools
that we all, that science as a whole gets faster.
I think it's incredibly important for science
to contribute to the world, to the problems,
to, you know, the incredible burden of disease, right?
We have to, and why is drug discovery hard?
It's not just because people don't spend money.
They spend a tremendous amount of money on drug discovery.
Drug discovery is hard
because we don't understand biology, right?
We need to understand the science of that
to build the right medicines.
We need to be able to ultimately, you know,
protein for how the cell moves atoms around
on the nanoscale.
And it's really, really, you know,
in a lot of the chemistry we wanna do,
nature does it better, does it more efficiently.
And so how are we going to ultimately engineer that?
How are we gonna solve all these problems?
Because it gives us a new type of technology
and that enables us to cure disease,
to engineer new things.
It's really, really essential.
And I think it's, you know, ever more, you know,
apparent to people after the pandemic, you know,
how weak we ultimately are in the face of disease,
how challenging it still is despite all our investments
and all our technology.
I feel like I'm in this field, I think for two reasons.
One, maybe the biggest is I kind of love it.
I love this kind of challenge and uncertainty
and just like trying to solve these problems.
And I think trying to solve these beautiful problems
of like, how do atoms move?
How did nature evolve kind of exquisite systems
out of randomness?
I think that's extraordinary.
And I think the other reason I particularly love
being in biology is it's such a clear path to the end.
It's such a clear path that if I do this work well,
then someone who doesn't care about the laws of the universe
but might care, you know, or does care
that their relatives come home from the hospital.
And that to me is deeply important.
And it's so, you know, I'm certain now that,
you know, maybe not yet, but in the next few years
that there will be people who live
because of the work we did.
And then not a direct drug from us,
but the insights lead someone else to build a medicine,
lead someone else to treat a disease
and that there are people walking around
because I live my life in the way I did.
And that's humbling and gratifying.
I think there are many possibilities from AI.
I think one I'm really excited about,
or you're kind of close to my area,
is that we can meet the complexity of biology.
Just biology is big, enormous, wide, right?
There are 20,000 plus places in our DNA
that tell you how to build a protein, right?
And, you know, many of these have had incredible amounts
of study by scientists.
Many others haven't.
There is so much in a cell that I don't see
how we're gonna get there with, you know,
kind of one at a time studies.
We're gonna need to measure lots of data.
We're gonna need to put this into models.
We need to, like, meet that complexity.
So I think one of the big promises of AI
is that we will understand how the cell works.
And it's hard to see how we get there without it.
And then we will have some idea of what happens
when we do a treatment,
that we will basically shorten this incredible
and terrible cost of drug development
because we understand the biology better.
And if we knew, you know,
if we know exactly what to go after,
I think it's more direct than right now
we don't know what to go after.
I think the other kind of big promise of AI in this field
and what David's work is justly rewarded for the Nobel
is that we'll be able to engineer proteins
that will ultimately be therapeutics
that will possibly be the dominant therapeutics
and that we will treat disease faster and better.
And so I think, like, local to my area,
I think there's a real promise
that AI will help us solve this scientific problem,
hopefully others, and we don't know for sure.
One of the things I will say
is that we benefited from an incredible data source,
the Protein Data Bank.
It was collected over many, many years,
and there aren't too many of those in science.
So there is a question of how much further
will we be able to push this?
How many, will we have a couple of problems
that are transformed by AI
and many others that got no faster?
And then will those problems be enough
to really deliver the benefits we want?
We don't know yet.
I think we should have a humility about it.
But there is a promise that it can do quite a lot.
And I think it's, you know,
this prize is also really exciting
because it's an acknowledgement
that AI solved a problem that, you know,
humans couldn't by any other means.
And it's, you know, maybe different in a kind
from some of the work that's done
with language models or image generators
where they're doing incredible outputs
that look like a human could have made them, right?
And that's the high compliment.
But AlphaFold is about, you know,
building something, solving a problem
that we had no other way to do it.
It's not like you, well, other than experiments.
But there is no way that you could do it
without experiments.
No amount of human thought or cognition
is honestly any good at all.
It's all at predicting the structure of proteins.
There's no person who thinks about it real hard
and then writes out the protein structure.
So I think it's the promise that we will solve
these grand scientific problems as well.
Oh, my wife is so terribly important to my career.
I, you know, a counselor, an advocate,
you know, pushing me to stop doing the things I shouldn't
and pay attention to the right things.
I mean, I would not, I would not have been able
to do this without Carolyn.
She's extraordinary and, you know,
she unfortunately didn't get her PhD
because the advisors kept leaving the university
after a year and a half.
And that makes me sad,
but she's absolutely been behind me
the whole way and extraordinary.
